Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Unknown 1Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 66Colonic Neoplasms 31Rectal Neoplasms 30Pancreatic Neoplasms 18Stomach Neoplasms 16Carcinoma, Hepatocellular 14Neoplasm Metastasis 13Esophageal Neoplasms 6Leukemia 5Neoplasms 4Lymphoma 4Liver Neoplasms 3Cholangiocarcinoma 3Carcinoma 3Adenocarcinoma Of Esophagus 3Solid Tumors 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neutropenia 2Leukemia, Biphenotypic, Acute 2Gastrointestinal Neoplasms 2Gallbladder Neoplasms 2Colorectal Cancer Metastatic 2Carcinoma, Squamous Cell 2Breast Neoplasms 2Biliary Tract Neoplasms 2Bile Duct Neoplasms 2mCRC 1Unresectable Sinonasal Tumors 1Thymoma 1Small Cell Lung Carcinoma 1

Interventions

Sodium Chloride 2Paclitaxel 2Oxaliplatin 2Folfox protocol 2Carboplatin 2Taxes 1Saline Solution 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Pharmacogenomic Testing 1Leucovorin 1Gene Expression Profiling 1Fluorouracil 1Brachytherapy 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Neurotoxicity Syndromes × Leucovorin × Clear all
NCT00884767 2009-07-08

Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin

National Cancer Institute (NCI)

Phase 2 Unknown
206 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡